Abbott’s 3Q drug sales up 22 percent, net income drops on restructuring, recall costs
Abbott Laboratories, a maker of drugs and medical devices, fell after it reported third-quarter sales that missed analysts estimates. The shares dropped 45 cents, or less than 1 percent, to $52.42 at 4:03 p.m. in New York Stock Exchange composite tra...